Turan: Neuralink, Elon Musk's innovator company in the field of brain-computer interfaces (BCIS), received approval from the US Food and Drug Administration (FDA) to conduct clinical trials of implanting a Neuralink implant about six months ago. Now, the company is actively seeking a volunteer patient under the age of 40 who suffers from paralysis in their arms and legs. The aim of this groundbreaking operation is to demonstrate the device's abil...

Please login or subscribe to read more

Leave a review

In World

Follow us on social networks

In Focus